| RS137853207 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853208 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853209 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853210 |
DDC
|
Health Risk |
Pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853211 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853212 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS137853214 |
RASA1
|
Health Risk |
Pathogenic |
Basal cell carcinoma, somatic |
| RS137853215 |
RASA1
|
Health Risk |
Pathogenic |
Basal cell carcinoma, somatic |
| RS137853217 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS137853218 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Vascular malformation |
| RS137853219 |
GH1
|
Health Risk |
Pathogenic |
Ateleiotic dwarfism, Ateleiotic dwarfism |
| RS137853220 |
GH1
|
Health Risk |
Pathogenic |
Short stature due to growth hormone qualitative anomaly, Short stature due to growth hormone qualitative anomaly |
| RS137853221 |
GH1
|
Health Risk |
Pathogenic |
Short stature due to growth hormone qualitative anomaly, Short stature due to growth hormone qualitative anomaly |
| RS137853222 |
GH1
|
Health Risk |
Pathogenic |
Short stature due to growth hormone qualitative anomaly, Short stature due to growth hormone qualitative anomaly |
| RS137853223 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Autosomal dominant isolated somatotropin deficiency |
| RS137853224 |
KRT1
|
Health Risk |
Pathogenic |
Epidermolytic ichthyosis, Epidermolytic ichthyosis |
| RS137853226 |
GNAI2
|
Health Risk |
Pathogenic |
Thecoma, somatic |
| RS137853227 |
GNAI2
|
Health Risk |
Pathogenic |
Ovarian granulosa cell tumor, Adrenocortical tumor |
| RS137853228 |
GNAI2
|
Health Risk |
Pathogenic |
Ventricular tachycardia, somatic |
| RS137853229 |
RECQL4
|
Health Risk |
Pathogenic |
Rothmund-Thomson syndrome, Baller-Gerold syndrome |
| RS137853230 |
RECQL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Rapadilino syndrome, Rapadilino syndrome |
| RS137853231 |
RECQL4
|
Health Risk |
Pathogenic |
Rapadilino syndrome, Baller-Gerold syndrome |
| RS137853232 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, RECQL4-related disorder |
| RS137853235 |
HGF
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 39, Autosomal recessive nonsyndromic hearing loss 39 |
| RS137853236 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, 6 conditions |
| RS137853237 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS137853238 |
HNF1A
|
Health Risk |
Pathogenic |
Type 1 diabetes mellitus 20, Monogenic diabetes |
| RS137853242 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS137853243 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS137853244 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS137853245 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS137853248 |
HSPG2
|
Health Risk |
Pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS137853249 |
HK1
|
Health Risk |
Pathogenic |
Hemolytic anemia due to hexokinase deficiency, Hemolytic anemia due to hexokinase deficiency |
| RS137853250 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, See cases |
| RS137853251 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853252 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Inborn genetic diseases |
| RS137853253 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853254 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853255 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853256 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853257 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853258 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, PDHA1-related disorder |
| RS137853259 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS137853260 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS137853261 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS137853262 |
OCRL
|
Health Risk |
Pathogenic |
Dent disease type 2, Dent disease type 2 |
| RS137853263 |
OCRL
|
Health Risk |
Likely pathogenic |
Dent disease type 2, Lowe syndrome |
| RS137853264 |
FGD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS137853266 |
FGD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aarskog syndrome, Inborn genetic diseases |
| RS137853267 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS137853268 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS137853269 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS137853270 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS137853271 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphataemia or rickets |
| RS137853272 |
BRWD3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 93 |
| RS137853273 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial calcification, generalized |
| RS137853279 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS137853280 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Developmental and epileptic encephalopathy 93 |
| RS137853281 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Inborn genetic diseases |
| RS137853282 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS137853283 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Inborn genetic diseases |
| RS137853284 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS137853285 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS137853287 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Inborn genetic diseases |
| RS137853289 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4A |
| RS137853290 |
RLBP1
|
Health Risk |
Pathogenic |
Pigmentary retinal dystrophy, Retinitis punctata albescens |
| RS137853291 |
RLBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis punctata albescens, RLBP1-related disorder |
| RS137853292 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS137853293 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS137853294 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS137853295 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS137853296 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS137853297 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS137853298 |
TIMP3
|
Health Risk |
Pathogenic |
Sorsby fundus dystrophy, Retinal disorder |
| RS137853299 |
TIMP3
|
Health Risk |
Pathogenic |
Sorsby fundus dystrophy, Sorsby fundus dystrophy |
| RS137853300 |
TIMP3
|
Health Risk |
Pathogenic |
Sorsby fundus dystrophy, Retinal dystrophy |
| RS137853301 |
TIMP3
|
Health Risk |
Pathogenic |
Sorsby fundus dystrophy, Sorsby fundus dystrophy |
| RS137853302 |
TIMP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS137853304 |
ABL1
|
Health Risk |
Pathogenic |
Chronic myelogenous leukemia, BCR-ABL1 positive |
| RS137853305 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS137853306 |
TPM2
|
Health Risk |
Pathogenic |
Congenital myopathy 23, Arthrogryposis |
| RS137853307 |
TPM2
|
Health Risk |
Likely pathogenic |
Congenital myopathy 23, Arthrogryposis |
| RS137853310 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS137853311 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS137853312 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontometaphyseal dysplasia 1, Oto-palato-digital syndrome |
| RS137853313 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS137853314 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type I |
| RS137853315 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS137853316 |
FLNA
|
Health Risk |
Pathogenic |
Otopalatodigital syndrome spectrum disorder, Otopalatodigital syndrome spectrum disorder |
| RS137853317 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type I |
| RS137853318 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS137853320 |
BMP15
|
Health Risk |
Pathogenic |
Premature ovarian failure 4, Premature ovarian failure 4 |
| RS137853321 |
IKBKG
|
Health Risk |
Pathogenic |
Incontinentia pigmenti syndrome, ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1 |
| RS137853322 |
IKBKG
|
Health Risk |
Conflicting classifications of pathogenicity |
Incontinentia pigmenti syndrome, Incontinentia pigmenti syndrome |
| RS137853323 |
IKBKG
|
Health Risk |
Pathogenic |
Incontinentia pigmenti syndrome, Incontinentia pigmenti syndrome |
| RS137853324 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS137853325 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS137853326 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS137853327 |
IKBKG
|
Health Risk |
Likely pathogenic |
ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED |
| RS137853328 |
IKBKG
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |